KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001860131-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 20, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,001
Total Value
$17,445.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Feb 17, 2026 | Exercise/Conversion | 2,419 | โ | โ | 134,250 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Feb 18, 2026 | Sale | 1,163 | $15.00 | $17,445.00 | 133,087 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | Feb 17, 2026 | Exercise/Conversion | 2,419 | $0.00 | $0.00 | 2,419 | Direct | โ | View Details |